InVitae (NVTA) Tops Q3 EPS by 2c

InVitae (NYSE: NVTA) reported Q3 EPS of ($0.45), $0.02 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $37.66 million versus the consensus estimate of $34.74 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• Stantec (STN) Tops Q2 EPS by 47c